Tissue Financial Statements From 2010 to 2025

Stocks . UK . 
Stock . Tissue Regenix Group
TRX Stock   58.50  1.50  2.50%   
Tissue Regenix financial statements provide useful quarterly and yearly information to potential Tissue Regenix Group investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Tissue Regenix financial statements helps investors assess Tissue Regenix's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Tissue Regenix's valuation are summarized below:
Gross Profit
11.3 M
Profit Margin
(0.03)
Exchange Market
LSE - AIM
Market Capitalization
42.7 M
Enterprise Value Revenue
1.8611
There are over eighty-eight available fundamental trend indicators for Tissue Regenix Group, which can be analyzed over time and compared to other ratios. Investors should ensure to double-check all of Tissue Regenix's current performance against the performance from 2010 to 2025 to make sure the company is sustainable down the road.

Tissue Regenix Total Revenue

35.61 Million

Check Tissue Regenix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tissue Regenix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Interest Expense of 1 M or Selling General Administrative of 10.2 M, as well as many indicators such as . Tissue financial statements analysis is a perfect complement when working with Tissue Regenix Valuation or Volatility modules.
  
This module can also supplement various Tissue Regenix Technical models . Check out the analysis of Tissue Regenix Correlation against competitors.

Tissue Regenix Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets30.2 M49.7 M33.1 M
Slightly volatile
Total Stockholder Equity25.9 M34.7 M27.6 M
Pretty Stable
Common Stock Total Equity14.2 M13.5 M7.2 M
Slightly volatile
Liabilities And Stockholders Equity30.3 M49.7 M33.1 M
Slightly volatile
Other Stockholder Equity186.4 M177.5 M96.7 M
Slightly volatile
Total Liabilities16.8 M16 M6.6 M
Slightly volatile
Common Stock99.4 K104.7 K5.2 M
Very volatile
Common Stock Shares Outstanding80.5 M81 M87.6 M
Very volatile
Other Current Liabilities1.6 M3 M1.7 M
Slightly volatile
Total Current Liabilities5.7 M5.4 M3.1 M
Slightly volatile
Property Plant And Equipment Net10.9 M10.4 M3.9 M
Slightly volatile
Accounts Payable921 K1.4 M973.2 K
Slightly volatile
Cash4 M4.2 M14 M
Slightly volatile
Non Current Assets Total29.2 M27.8 M13.1 M
Slightly volatile
Cash And Short Term Investments4 M4.2 M14 M
Slightly volatile
Net Receivables2.1 M2.7 M2.3 M
Slightly volatile
Good Will9.1 M10.4 M12.1 M
Pretty Stable
Non Current Liabilities Total11.1 M10.5 M3.9 M
Slightly volatile
Other Current Assets4.9 M4.7 M1.5 M
Slightly volatile
Property Plant And Equipment Gross17.4 M16.6 M5.3 M
Slightly volatile
Total Current Assets20.8 M22 M21.4 M
Slightly volatile
Intangible Assets3.9 M4.1 M8.1 M
Pretty Stable
Property Plant Equipment10.8 M10.3 M4.1 M
Slightly volatile
Net Tangible Assets17.7 M20.2 M17.1 M
Very volatile
Inventory12.5 M11.9 M4.3 M
Slightly volatile
Capital Surpluse88.9 M108.4 M74.2 M
Slightly volatile
Deferred Long Term Liabilities1.7 M1.6 M786.5 K
Slightly volatile
Other Liabilities618.7 K468 K1 M
Slightly volatile
Net Invested Capital38.4 M41.6 M37.7 M
Slightly volatile
Net Working Capital15.8 M16.5 M16.5 M
Slightly volatile
Capital Stock77.8 K81.9 K6.4 M
Slightly volatile
Short and Long Term Debt Total6.8 M10.8 M4.3 M
Slightly volatile
Long Term Debt4.4 M6.4 M3.1 M
Slightly volatile
Short Term Debt530.6 K738.3 K326.2 K
Slightly volatile
Capital Lease Obligations3.5 M3.9 M2.8 M
Slightly volatile

Tissue Regenix Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.2 M1.1 M620.8 K
Slightly volatile
Selling General Administrative10.2 M16.6 M11.1 M
Slightly volatile
Total Revenue35.6 M33.9 M11.2 M
Slightly volatile
Other Operating Expenses36.1 M34.4 M17 M
Slightly volatile
Total Operating Expenses10.6 M16.6 M10.4 M
Slightly volatile
Research Development596.5 K627.9 K1.6 M
Slightly volatile
Selling And Marketing Expenses3.2 M2.5 M5.1 M
Slightly volatile
Interest Income28.9 K23.4 K64.1 K
Slightly volatile
Reconciled Depreciation1.1 M1.1 M877.9 K
Slightly volatile

Tissue Regenix Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation502.5 K903.9 K552.8 K
Slightly volatile
Capital Expenditures569.6 K992.5 K656.3 K
Slightly volatile
End Period Cash Flow4 M4.2 M14 M
Slightly volatile
Sale Purchase Of Stock15.7 M16.8 M11.9 M
Slightly volatile
Net Borrowings1.3 M1.5 M1.9 M
Slightly volatile

Tissue Fundamental Market Drivers

Forward Price Earnings112.3596
Cash And Short Term Investments4.7 M

About Tissue Regenix Financial Statements

Tissue Regenix stakeholders use historical fundamental indicators, such as Tissue Regenix's revenue or net income, to determine how well the company is positioned to perform in the future. Although Tissue Regenix investors may analyze each financial statement separately, they are all interrelated. For example, changes in Tissue Regenix's assets and liabilities are reflected in the revenues and expenses on Tissue Regenix's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Tissue Regenix Group. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue 2.30  2.42 
Total Revenue33.9 M35.6 M
Cost Of Revenue17.8 M18.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
SSentinelOne
CRMSalesforce
MSFTMicrosoft

Other Information on Investing in Tissue Stock

Tissue Regenix financial ratios help investors to determine whether Tissue Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tissue with respect to the benefits of owning Tissue Regenix security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY